| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CryoLife Inc (NYSE: CRY)
CRY Technical Analysis
1.5
| As on 24th Mar 2022 CRY SHARE Price closed @ 20.25 and we RECOMMEND Sell for LONG-TERM with Stoploss of 24.55 & Buy for SHORT-TERM with Stoploss of 20.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRYSHARE Price
| Open | 19.66 | Change | Price | % |
| High | 20.26 | 1 Day | -0.39 | -1.89 |
| Low | 19.60 | 1 Week | 1.00 | 5.19 |
| Close | 20.25 | 1 Month | 2.34 | 13.07 |
| Volume | 94464 | 1 Year | 1.78 | 9.64 |
| 52 Week High 32.07 | 52 Week Low 16.76 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| CRY Daily Charts |
CRY Intraday Charts |
Whats New @ Bazaartrend |
CRY Free Analysis |
|
|
CRY Important Levels Intraday
| RESISTANCE | 21.52 |
| RESISTANCE | 21.11 |
| RESISTANCE | 20.86 |
| RESISTANCE | 20.61 |
| SUPPORT | 19.89 |
| SUPPORT | 19.64 |
| SUPPORT | 19.39 |
| SUPPORT | 18.98 |
CRY Forecast April 2024
| 4th UP Forecast | 30.42 |
| 3rd UP Forecast | 27.16 |
| 2nd UP Forecast | 25.14 |
| 1st UP Forecast | 23.13 |
| 1st DOWN Forecast | 17.37 |
| 2nd DOWN Forecast | 15.36 |
| 3rd DOWN Forecast | 13.34 |
| 4th DOWN Forecast | 10.08 |
CRY Weekly Forecast
| 4th UP Forecast | 22.97 |
| 3rd UP Forecast | 22.10 |
| 2nd UP Forecast | 21.56 |
| 1st UP Forecast | 21.02 |
| 1st DOWN Forecast | 19.48 |
| 2nd DOWN Forecast | 18.94 |
| 3rd DOWN Forecast | 18.40 |
| 4th DOWN Forecast | 17.53 |
CRY Forecast2024
| 4th UP Forecast | 50.66 |
| 3rd UP Forecast | 40.91 |
| 2nd UP Forecast | 34.88 |
| 1st UP Forecast | 28.85 |
| 1st DOWN Forecast | 11.65 |
| 2nd DOWN Forecast | 5.62 |
| 3rd DOWN Forecast | -0.41 |
| 4th DOWN Forecast | -10.16 |
CryoLife Inc ( NYSE USA Symbol : CRY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRY Business Profile
CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. Address: 1655 Roberts Boulevard N.W., Kennesaw, GA, United States, 30144
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service